West Pharmaceutical
250 hedge funds and large institutions have $4.71B invested in West Pharmaceutical in 2016 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 96 increasing their positions, 83 reducing their positions, and 26 closing their positions.
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
16% more capital invested
Capital invested by funds: $4.05B → $4.71B (+$663M)
16% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 83
12% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 26
1% more funds holding
Funds holding: 248 → 250 (+2)
0.64% more ownership
Funds ownership: 93.49% → 94.13% (+0.64%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
+$54.2M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$45.5M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$23.3M |
| 4 |
Goldman Sachs
New York
|
+$20.6M |
| 5 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$19.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KI
Kalmar Investments
Greenville,
Delaware
|
-$29.4M |
| 2 |
RCG
Ruane, Cunniff & Goldfarb
New York
|
-$27.6M |
| 3 |
RIM
RS Investment Management
San Francisco,
California
|
-$20.2M |
| 4 |
Neuberger Berman Group
New York
|
-$13.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$13M |
WST Hedge Fund Activity: Q1 2016 in Review
250 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q1 2016, worth a combined $4.71B — up 16% from $4.05B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new WST positions and 26 closed out — a net gain of 3 holders — while 96 added to existing stakes and 83 trimmed.
The largest buyer was Select Equity Group, adding an estimated $54.2M. The largest seller was Kalmar Investments, cutting an estimated $29.4M.
- 250 institutional investors held West Pharmaceutical (WST) as of Q1 2016, up from 248 in Q4 2015.
- Funds reported $4.71B of West Pharmaceutical stock for Q1 2016, up 16% quarter-over-quarter.
- 29 funds opened new West Pharmaceutical positions in Q1 2016 and 26 closed out, a net change of +3 holders.
- The largest West Pharmaceutical buyer in Q1 2016 was Select Equity Group, an estimated $54.2M added.
- The largest West Pharmaceutical seller in Q1 2016 was Kalmar Investments, an estimated $29.4M sold.
Based on aggregated 13F filings for Q1 2016.